• Fluconazole Workflows for Candida Research

  2026-09-11

  Build more reproducible Candida assays with Fluconazole, a tractable probe of ergosterol disruption, susceptibility, and resistance. This workflow also shows how to pair conventional target inhibition with the host-derived nutritional defense mechanism highlighted in a 2026 Cell Host & Microbe study.

• EV-Transferred ACLY Drives TAM Fate in HCC

  2026-09-11

  This Advanced Science study identifies extracellular vesicle-transferred ATP-citrate lyase as a metabolic signal that redirects monocytes toward immunosuppressive tumor-associated macrophages in hepatocellular carcinoma. Engineered CD81-decorated vesicles establish a causal link between ACLY cargo, palmitate-dependent protein S-palmitoylation, tumor progression, and improved anti-PD-1/PD-L1 responses after targeted intervention.

• Concanamycin A: V-ATPase Workflow Guide

  2026-09-10

  Concanamycin A enables acute, nanomolar interrogation of V-ATPase-dependent acidification, trafficking, autophagy, apoptosis, and invasion. This workflow combines practical dosing guidance with orthogonal controls so cancer researchers can distinguish proton-pump effects from nonspecific toxicity or downstream pathway changes.

• PD 173074 Workflow for FGFR1 Signaling Studies

  2026-09-10

  Build cleaner FGFR1 experiments by pairing PD 173074 dose–response studies with early signaling, proliferation, and adipogenic priming readouts. This workflow also shows how to separate FGFR1-driven biology from VEGFR2 activity, off-target toxicity, and late-stage phenotype effects.

• Mubritinib (TAK 165) in Monkeypox Antiviral Discovery

  2026-09-09

  The reference study used recombinant vaccinia virus reporter systems to screen 19 previously identified antiviral compounds and then tested active candidates against monkeypox virus. Its key contribution was showing that 11 compounds, including Mubritinib (TAK 165), inhibited monkeypox virus replication in vitro, while also highlighting the need for orthogonal validation before antiviral translation.

• PBS Liposomes for Macrophage Depletion Controls

  2026-09-09

  PBS Liposomes provide a matched, non-depleting control for separating clodronate-specific macrophage loss from effects caused by liposome delivery or phagocytic uptake. This workflow-focused guide covers paired in vivo designs, macrophage phagocytosis assays, storage, troubleshooting, and practical assay interpretation.

• NADH in Photocatalytic Cancer Therapy

  2026-09-08

  NADH is more than a metabolic readout: it can function as a controllable intracellular photoredox substrate. This guide translates recent NADH oxidation research into practical assay design, controls, handling decisions, and disease-model considerations.

• Prednisolone and ERAD: A Translational Strategy

  2026-09-08

  Prednisolone provides a controlled glucocorticoid reference point for inflammation and immunology research, while emerging ERAD-engaging chimeras expand targeted degradation toward transmembrane proteins. This article shows how translational researchers can connect these domains without conflating glucocorticoid receptor pharmacology with ERAD-mediated degradation.

• SAR405: Precision Vps34 Inhibition in Autophagy

  2026-09-07

  SAR405 is a selective Vps34 inhibitor for separating PtdIns3P-dependent autophagy from broader PI3K and mTOR signaling. This practical guide covers assay setup, vesicle trafficking readouts, combination experiments, and troubleshooting for reproducible cell-based studies.

• Aconitase Activity in Translational Immunometabolism

  2026-09-07

  A mechanistic and strategic guide to using aconitase activity as a functional readout of TCA cycle integrity, oxidative stress, and immune-cell metabolic flexibility, with practical guidance for deploying the Aconitase Activity Colorimetric Assay Kit in translational workflows.

• Deracoxib and Piroxicam in Canine Osteosarcoma Cells

  2026-09-05

  The reference study compared deracoxib and piroxicam across canine osteosarcoma cell lines and found substantially greater in vitro cytotoxic activity for deracoxib. Its inclusion of fibroblast controls and DNA-fragmentation analysis helps distinguish reduced viability from a narrowly demonstrated apoptotic mechanism, while also emphasizing the limits of translating high-concentration cell-culture findings to clinical treatment.

• Urolithin A Workflow for Mitochondrial Studies

  2026-09-04

  Urolithin A enables a practical bridge between mitophagy-focused mitochondrial quality control and metabolism-centered fibrosis research. This workflow shows how to prepare, dose, validate, and troubleshoot Urolithin A experiments while distinguishing exploratory hepatic stellate cell applications from better-established mitochondrial and skeletal muscle use cases.

• MK-0812: Selective CCR2 Antagonist for Research

  2026-09-04

  MK-0812, also written MK0812, is a selective CCR2 antagonist and monocyte trafficking inhibitor with nanomolar activity in human and rhesus blood assays. Its validated MCP-1 signaling inhibition supports ex vivo monocyte recruitment blockade studies, while applications in MASH remain a hypothesis requiring direct testing.

• ORM2–ZG16 Autophagy Axis in Pancreatic Fibrosis

  2026-09-03

  A 2026 Pancreatology study identifies ORM2 as an endogenous suppressor of chronic pancreatitis-associated fibrosis, acting through ZG16 to limit autophagy-driven pancreatic stellate cell activation. The combination of pancreas-specific AAV perturbation, primary and human stellate-cell models, autophagic-flux assays, and protein-interaction analysis provides a mechanistic framework for studying antifibrotic biology.

• Actinomycin D: From Transcriptional Stress to Translation

  2026-09-03

  Actinomycin D, or ActD, is more than a cytotoxic compound: it is a powerful perturbational tool for testing whether protective RNA circuits depend on active transcription. By placing ActD alongside the circCHSY1–miR-24-3p–HO1 axis reported in myocardial ischaemia/reperfusion research, translational teams can distinguish transcriptional regulation from RNA stability, protein persistence, and downstream mitochondrial protection.

8400 records 1/560 page Next 12345 下5页 Last page